Okuno K, Hamaoka T
Gan To Kagaku Ryoho. 1982 Dec;9(12):2053-64.
Lymphokines are defined as nonimmunoglobulin secretory products of activated lymphocytes with a wide range of potent physiological effects on inflammation and immune responses. In this review, we summarized the recent development in lymphokine researches, including biochemical and immunological approaches. An increasing number of assay methods enabled us to detect various lymphokine activities released in the culture medium of lectin activated lymphoid cells. However, some of the results in a number of independent studies about lymphokines were rather complicated for precise interpretation, since the lymphoid cell-culture medium comprises a mixture of very heterogeneous lymphokines molecules. This problem has now been overcome by generating hybridomas producing rather homogeneous lymphokine. By utilizing such relatively homogeneous lymphokines, we analyzed the mechanism of cytoxic T lymphocyte (CTL) generation, and discussed a possibility for utilization of this approach to the future antitumor immunotherapy.
淋巴因子被定义为活化淋巴细胞分泌的非免疫球蛋白产物,对炎症和免疫反应具有广泛的强大生理作用。在这篇综述中,我们总结了淋巴因子研究的最新进展,包括生化和免疫学方法。越来越多的检测方法使我们能够检测凝集素激活的淋巴细胞培养基中释放的各种淋巴因子活性。然而,一些关于淋巴因子的独立研究结果相当复杂,难以精确解释,因为淋巴细胞培养基包含非常异质的淋巴因子分子混合物。现在,通过产生产生相当均质淋巴因子的杂交瘤,这个问题已经得到克服。通过利用这种相对均质的淋巴因子,我们分析了细胞毒性T淋巴细胞(CTL)产生的机制,并讨论了将这种方法应用于未来抗肿瘤免疫治疗的可能性。